Impact of anticoagulation before stroke on stroke severity and long-term survival

International Journal of Stroke

Volumn 7, Issue 7, 2012, Pages 544-550

  Haeusler, Karl Georg ^a   Konieczny, Maria ^a   Endres, Matthias ^a   Villringer, Arno ^b,c   Heuschmann, Peter U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Anticoagulation; Antithrombotic therapy; Atrial fibrillation; Ischemic stroke; Long term mortality; Morbidity

Indexed keywords

ANTIVITAMIN K;

ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISABILITY; DISEASE SEVERITY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; INDEPENDENT VARIABLE; INTERNATIONAL NORMALIZED RATIO; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPLE REGRESSION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STROKE; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL RATE;

EID: 84866501539     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00672.x     Document Type: Article

References (30)

1. Go AS, Hylek EM, Phillips KA etal. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285:2370-2375.
2. Heeringa J, van der Kuip DA, Hofman A etal. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27:949-953.
3. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22:983-988.
4. Nieuwlaat R, Dinh T, Olsson SB etal. Should we abandon the common practice of withholding oral anticoagulation in paroxysmal atrial fibrillation? Eur Heart J 2008; 29:915-922.
5. Lip GY. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis. Thromb Haemost 2008; 100:11-13.
6. Lin HJ, Wolf PA, Kelly-Hayes M etal. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996; 27:1760-1764.
7. Marini C, De Santis F, Sacco S etal. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 2005; 36:1115-1119.
8. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146:857-867.
9. Fuster V, Rydén LE, Asinger RW etal. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. Circulation 2001; 104:2118-2150.
10. Fuster V, Ryden LE, Cannom DS etal. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Europace 2006; 8:651-745.
11. Laguna P, Martn A, del Arco C, Gargantilla P. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? The GEFAUR-1 study. Ann Emerg Med 2004; 44:3-11.
12. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2006; 27:1954-1964.
13. Dinh T, Nieuwlaat R, Tieleman RG etal. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands - The EXAMINE-AF study. A questionnaire survey. Int J Clin Pract 2007; 61:24-31.
14. Gattellari M, Worthington J, Zwar N, Middleton S. Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians. Stroke 2008; 39:227-230.
15. Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Am J Geriatr Pharmacother 2009; 7:159-166.
16. Hylek EM, Go AS, Chang Y etal. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349:1019-1026.
17. O'Donnell M, Oczkowski W, Fang J etal. Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol 2006; 5:749-754.
18. Audebert HJ, Schenk B, Schenkel J, Heuschmann PU. Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation. Cerebrovasc Dis 2010; 29:476-483.
19. Indredavik B, Rohweder G, Lydersen S. Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation. J Intern Med 2005; 258:133-144.
20. Schwammenthal Y, Bornstein N, Schwammenthal E etal. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]). Am J Cardiol 2010; 105:411-416.
21. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976; 54:541-553.
22. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285:2864-2870.
23. Brott T, Adams HP Jr, Olinger CP etal. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20:864-870.
24. Savitz SI, Lew R, Bluhmki E, Hacke W, Fisher M. Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials. Stroke 2007; 38:3205-3212.
25. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-607.
26. Burgess C, Ingham T, Woodbridge M, Weatherall M, Nowitz M. The use of antithrombotics in patients presenting with stroke and atrial fibrillation. Ther Clin Risk Manag 2007; 3:491-498.
27. Glader EL, Stegmayr B, Norrving B etal. Large variations in the use of oral anticoagulants in stroke patients with atrial fibrillation: a Swedish national perspective. J Intern Med 2004; 255:22-32.
28. Nieuwlaat R, Capucci A, Lip GY etal. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2006; 27:3018-3026.
29. Wan Y, Heneghan C, Perera R etal. Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review. Circ Cardiovasc Qual Outcomes 2008; 1:84-91.
30. Ay H, Arsava EM, Gungor L etal. Admission international normalized ratio and acute infarct volume in ischemic stroke. Ann Neurol 2008; 64:499-506.